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extracted from cells or tissues till requires tedious purification Abstract The ability of antiganglioside antibodies to detect 
their respective antigens in various environments was studied. In procedures [18-20,22]. Nevertheless, the specific antiganglio- 
contrast o sensitive detection of pure ganglioside standards by side antibodies eem to provide a convenient tool to detect 
ELISA, antibody binding to mixtures of ganglinsides was small amounts of ganglioside antigen in a sample. Conse- 
drastically reduced. This loss of sensitivity also occurred with quently, the ability of such antibodies to bind their respective 
immunostaining of gangliosides absorbed to silica gel. Moreover, antigens in different environments was tested. This study de- 
absorption of antibodies to antigen-containing lipid vesicles monstrates a dramatic loss of the antibodies' sensitivity if 
failed, if the vesicles were prepared together with other ganglio- ganglioside species other than the respective antigens are pre- 
sides. These data indicate that antigen accessibility is strongly sent in a sample. 
influenced by surrounding gangliosides. This should be consid- 
ered whenever gangliosides are traced by antibodies. The ELISA 
procedure appears useful to test for such properties. 2. Materials and methods 
Key words: Glycosphingolipid; Sialic acid; Antigen 2.1. Materials 
accessibility; Membrane glycolipid; Tumor marker; Cell HRP-labelled cholera toxin B subunit (CT-B-HRP) was from RBI 
surface (Natick, MA, USA), dioleoylphosphatidylcholine (DOPC) from 
Avanti Biochemicals (Alabaster, AL, USA) and cholesterol from Sig- 
ma (Deisenhofen, Germany). TLC plates (Silica gel 60) were obtained 
from Merck (Darmstadt, Germany), Immulon-1 microtiter plates 
from Dynatech (Denkendorf, Germany). 
1. Introduction 
2.2. Antibodies 
During the last decades an increasing number of specific, IgM mAb GMB16, GMRI7 and GMR5 containing supernatants of 
hybridoma cells were kindly provided by Dr T. Tai, Tokyo. Affinity 
monoclonal antiganglioside antibodies have been generated, purified mAb R24, IgG3, was a gift from Dr K. Lloyd, New York. As 
They have been used to analyse the occurrence and biological determined by ELISA and immunostaining on TLC, GMB16 and 
functions of gangliosides (1) [2-7] and serve as powerful tools GMR5 were reported to be specific for GM1 and GTlb respectively, 
in the diagnosis and therapy of tumours of neuroectodermal whereas GMR17 strongly reacts with GDla, but showed some cross- 
origin such as melanoma or neuroblastoma [8-11]. Besides reactivity with GTlb and GMlb [15,16]. R24 initially was described 
to be specific for GD3 [23]. In a later study, however, some cross- 
binding to gangliosides in situ, antiganglioside antibodies reactivity to disialylparagloboside was reported [14]. Phosphatase la- 
were applied to trace gangliosides in vitro, mainly using ELI- belled secondary antibody (goat) against mouse IgG (whole molecule) 
SA or immuno-thin layer chromatography (immuno-TLC) was purchased from Sigma (Deisenhofen, Germany). 
[6,7,12-20]. Both techniques allow detection in the picomolar 
2.3. Standard gangliosides 
range. Particularly with the ELISA approach ganglioside anti- Gangliosides GD3, GM1, GDla, GTlb and a standard mixture 
gens could be determined in a sensitive, dose-dependent man- Gmix consisting of GM1 (22%), GDla (40%), GDlb (18%), GTlb 
ner [14-18]. But up to now ELISA has merely been applied to (20%) with traces of GQlb were purchased from Dr. Pallmann 
purified ganglioside standards in order to assess pecificity and GmbH (Munich, Germany). Purities of the standard gangliosides 
dilution of antibodies. Only the well known affinity of cholera were 99.8% (GDla, GD3), 99.2% (GM1), and 98% (GDla) as ana- 
lysed by two-dimensional TLC, staining with resorcinol or H2SO4 
toxin towards GM1 has been used in an ELISA-like assay to reagent and densitometric s anning (Pallmann, personal communica- 
estimate the amount of GM1 in ganglioside samples isolated tion). All standards were stored as 1 mM aqueous tock solutions. 
from neuro-2a and PC 12 cells [21]. On the other hand, the 
use of immuno-TLC is restricted since quantitative evaluation 2.4. Ganglioside xtraction 
A crude chloroform/methanol extract containing angliosides and 
is difficult [13] and TLC separation of gangliosides other polar lipids was prepared from homogenised rat brain. An ali- 
quot, corresponding to 15 mg of tissue (wet weight), was lyophilised, 
sonicated twice with cold acetone (500 ~tl, -20°C) and centrifuged at 
*Corresponding author. Fax: (49) (711) 459 3450. 10 000 × g for 10 min. The supernatant, containing non-polar lipids 
(but no detectable sialic acid), was discarded. To obtain all remaining 
Abbreviations." BSA, bovine serum albumin; CT-B, cholera toxin B lipids, the residue was dried and extracted twice with 500 I.tl chloro- 
subunit; DOPC, dioleoylphosphatidylcholine; ELISA, enzyme-linked form/methanol 1:1 according to Li and Ladisch [24,25]. After eva- 
immunosorbent assay; Gmix, standard ganglioside mixture as described poration of the solvent he combined chloroform/methanol extracts 
in section 2.3; HRP, horseradish peroxidase; HSA, human serum were redissolved in water. Aliquots were taken for determination f 
albumin; mAb, monoclonal antibody; PBS, phosphate-buffered lipid-bound sialic acid using the method of Svennerholm [26] as mod- 
saline; TLC, thin layer chromatography ified by Miettinen and Takki-Luukainen [27]. 
(t) Gangliosides are named according to the nomenclature of Sven- 2.5. Immunostaining on TLCplates 
nerholm [1]. Using a syringe, GmL~ was repeatedly applied as a fine line to the 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PI ISO0 1 4-5 793 (96)00503-0  
30 H. Hildebrandt/FEBS Letters 388 (1996) 29-33 
starting site of the TLC lane, separated by TLC using the solvent 1.0 
system chloroform/methanol/12 mM MGC12/37% NH3 60:40:9:0.1 a. R24 = b. GMR17 
and stained either by resorcinol spray [26] or by immuno-TLC as 0.8 . /  
described elsewhere [13,28]. If gangliosides absorbed to a TLC plate 10 ~ , ,  
were immunostained without previous separation, the respective t= 0.6. 
amount of ganglioside was applied by drops, c 
tel 
o 0 .4  
2.6. ELISA and GMl assay with CT-B-HRP ,('~ / , ~ ~ . , ~  
ELISA was performed according to Kotani et al. [16] and Ozawa et 0.2. . , i '~  ~%GOla 
al. [15], but alkaline phosphatase was used as a more convenient ,~ i . . . I '~  - 10%GD3= 
detection system and 2% BSA was used instead of HSA. To obtain 0.0. 
ganglioside mixtures at the desired concentration, samples or stan- 0 2'0 4'0 6'0 8"0 160 6 2'0 4'0 6.0 8"0 160 
dards were first combined and diluted with water and subsequently 
mixed with ethanol to give a 70% ethanol solution. Per well, 10 ~tl of pmo[ GD3 pmol GDla 
this solution was added to 50/.tl of ethanol, mixed and evaporated to 1.0 
complete dryness. After washing (PBS) and blocking (2% BSA in C. GMB16 7 d. GMR17 
PBS, 2 h) samples were incubated for 3 h (at room temperature) or 0.8 
overnight (at 4°C) with 100 gl of primary antibody in BSA-PBS. If I= 0.6 ~ ~ 
not stated otherwise, dilutions of 1:500 (mAb R24) or 1:20 (all other ~- 
mAbs) were used. After washing, alkaline phosphatase labelled sec- t~ 
ondary antibody (1:1000 in blocking buffer) was applied for 2 h ~ 0.4 
followed by another washing step and staining with p-nitrophenyl- 0.2 
phosphate in Tris-HC1, pH 8.8. Absorbance at 405 nm was deter- 
mined by a SLT ELISA plate reader. 0.0 4~¢'~ , 22% GMI^ 1 ,~ ^ ,,° 20%GTlb, 
Assays for GM1 using CT-B-HRP were performed according to 6 2'0 4'0 6'0 8'0 160 2'0 4'0 6'0 8'0 100 
Wu and Ledeen [21], but gangliosides were coated as described above. 
20 ng of CT-B-HRP was added per well and incubated for 1 h at pmol GM1 pmol GT lb  
room temperature. After washing with PBS and 0.1% Tween 20/PBS, 0.4 
CT-B-HRP was detected by the peroxidase substrate tetramethylben- e. CT-B-HRP ~ ;  
zidine (TMB, 0.4 mM in 1% H202/PBS). Reaction was stopped with 0.3 
10 ~tl 1 M H2SO4 and quantified at 450 nm. 1 ~  
E 0.2 
2. 7. Lipid vesicles o 
Mixed DOPC-cholesterol-ganglioside vesicles were prepared from a to 
chloroform/methanol (1:1, v/v) solution containing 500 nmol of <1~ 0.1 J . . , , ,~  22%GM1 
DOPC, 500 nmol of cholesterol and 20 nmol of ganglioside. After ~ , , "  T 
evaporation of the solvent under a gentle flow of N2 the lipids were 0.0 
redissolved in 500 ~tl n-hexane, shaken vigorously (overnight at 4°C) 
and dried again. After addition of 2 ml PBS (pH 7.4) the dispersion 0 1 2 :3 ,i 
was sonicated intensely, to obtain mixed vesicles (see [29] and refer- pmoI GM1 
ences therein). 
Fig. 1. Reactivity of four antiganglioside antibodies with different 
amounts of their respective ganglioside antigens determined by ELI- 
3. Results SA (a~l) compared to detection of GM 1 by CT-B-HRP (e). Gang- 
liosides were either coated as pure standards (100%, Q), a-e) or at 
ELISA was performed with different antibodies. Ganglio- the percentages indicated as part of Gmix (~e) or as addition of 
GD3 to Gmix (a). Values are means of 2-5 determinations ( +S.D. if 
side antigen was coated either as pure standard or as part of a n > 2). 
mixture of standard gangliosides. As shown in Fig. 1, detect- 
ing different concentrations of pure standard ganglioside by 
the appropriate antibody resulted in calibration curves that (Fig. 2b). Thus, antibody binding seems to depend mostly on 
were linear in the range of 10-100 pmol of ganglioside. How- the proportion of antigen relative to total ganglioside contents 
ever, if the microtitre plate was coated with the same amount and not on the absolute amount of ganglioside antigen. 
of the particular ganglioside antigen but mixed with other Therefore, to quantify the absolute amount of a ganglioside 
gangliosides (Gin=), a drastic decrease in sensitivity occurred, antigen by ELISA, standards and samples should have the 
In contrast, using CT-B-HRP for specific detection of GM1 same relative ganglioside composition, a prerequisite that can- 
[21], sensitivity decreased only slightly, if the relative amount not be accomplished for unknown samples. Trying to over- 
of GM1 was reduced to 22% of total ganglioside. To further come this difficulty, increasing amounts of standard ganglio- 
assess this inhibition of antibody binding due to the presence side antigen were added to aliquots of crude rat brain extract 
of gangliosides other than the respective antigen, the relative and the resulting calibration curve was extrapolated to esti- 
amount of antigen was varied in two ways. The relative mate the amount of antigen that had originally been present 
amount of e.g. GM1 was varied (i) by mixing different in this sample (Fig. 3). Since the relative amount of antigen 
amounts of GM1 and GDla  to a total of 100 pmol of gang- increased with addition of external antigen, a non-linear ise 
lioside or (ii) by adding different amounts of GDla  to a fixed in antibody sensitivity was expected (see Fig. 2), so that a 
amount of 100 pmol GM1. Fig. 2 demonstrates a non-linear linear regression tends to underestimate he amount of endo- 
increase of antibody binding with increasing relative amounts genous ganglioside. Nevertheless, the amount of 6.5 pmol 
of the ganglioside antigen. In both cases, i.e. with the fixed GD3 estimated by the linear extrapolation procedure (equal 
amount of 100 pmol GM1 as well as with the fixed amount of to 1.2% of total l ipid-bound sialic acid) closely matches pub- 
100 pmol total ganglioside, the binding increased strongly lished values of ganglioside composition determined for rat 
with decreasing amounts of GDla  added (Fig. 2a). The brain (1.1% GD3 [22]). In contrast, the estimated amount of 
same results were obtained with addition of GM1 to GDla  GDla  (20 pmol, 27% of total l ipid-bound sialic acid) is some- 
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0.8 ~[ was assessed by means of ELISA. Fig. 5 demonstrates that 
a. GMB16 ,~ b. GMR17 antibody binding to its specific antigen in ELISA was inhib- 
/~  T/',;; ited, if the antibody was preabsorbed to vesicle preparations 0.6 i "  • , containing the antigen as the only ganglioside. In contrast, 
c 0.4 / /  vesicle preparations containing mixtures of gangliosides failed 
o ~ ~ ' / '  to reduce specific antigen binding in ELISA. 
'~ 0.2 / ' /  
~ ,/,,~ ,_"~,'~ 4. Discussion 
6 2'0 4'0 6'0 8'0 160 6 2'0 4'0 6'0 8'0 160 In the present study it was tested whether antibodies direc- 
ted against major gangliosides of nerve and tumour cells 
% GM1 % GDla  [15,16,23] are able to detect heir respective antigens in gang- 
Fig. 2. Reactivity of mAb GMB16 (a) and mAb GMR17 (b) with lioside mixtures. Antibody binding was strongly reduced by 
different relative amounts of GM1 or GDla determined by ELISA. the presence of other gangliosides. This loss of antibody sen- 
Values are means (_+S.D.) of 3 determinations each. (a) GM1 and 
GDla were either mixed to a final amount of 100 pmol ganglioside sitivity occurred not only in ELISA, i.e. after ganglioside 
(C)) or increasing amounts of GDla were added to a fixed amount binding to a plastic surface, but also if gangliosides were ab- 
of 100 pmol GM1 (zx, 1 nmol of GDla was coated for the value at sorbed to silica gel TLC plates or incorporated into lipid 
0% GM1). (b) Same as (a) but GDla was used instead of GM1 vesicles. 
and vice versa. Quantitation of ganglioside was considered applying a 
method of standard addition to ELISA with crude ganglioside 
what lower than values reported in the literature (30-35% 
GDla [22,30]). Although GMR17 shows some cross-reactivity 
with GTlb and GMlb [161, controls with addition of 40 pmol a GM1 GDla GTlb 
of GTlb revealed no detectable increase of antibody binding ~ ~ 
(data not shown). Thus, GTlb, a major ganglioside of the rat I I ' 
brain, did not interfere with the present assay. 
In order to elucidate the influence of ganglioside composi- 
on antibody binding to samples absorbed to surfaces ~"~F '~ tion 
other than polystyrene, pure ganglioside antigen or Gmix ~ ~ 
were absorbed to TLC plates and immunostained without IQ I  
separation (Fig. 4a). In accordance to the results obtained 
by ELISA, clearly detectable antibody binding occurred 
only if the antibody was exposed to a surface impregnated 
with pure antigen. In a control experiment it was demon- 
strated that after TLC separation the antibodies were able Gmix Gmix Gmix 
to detect he ganglioside fractions contained in G~ix (Fig. 4b). 
The ability of antibodies to bind to gangliosides incorpo- GMB16 GMR17 GMR5 
rated into mixed phospholipid-cholesterol vesicles was ana- 
lysed in a pre-absorption experiment. Antibodies were incu- b I I I 
bated with vesicle preparations containing either a mixture of 
gangliosides or the respective antigen as the only ganglioside. G M 1 
Thereafter, unbound antibody in the antibody/vesicle solution 
E= GDlb  }I,.- 
GT1 b 
<0 0.02 __ -~  
•/ly= o.oolx + o.oo6s / / . (  R~ = 0.gg 6 / Y-- °p°0070x9~60"014 resorcinol immunostaining 
. . . . . . . . . . . . . . . .  staining GMB16 GMR17 GMR5 
-20-10 0 10 20 30 40 -20-10 0 10 20 30 40 Fig. 4. Immunostaining of Gmix or pure standard gangliosides 
pmol GD3 added pmol GDla  added dotted on TLC plates without separation (a) compared to resorcinol 
staining and immunostaining of Gmi~ separated by TLC (b). (a) 2 
Fig. 3. Reactivity of mAb R24 (a) and mAb GMR17 (b) in ELISA nmol of pure standard ganglioside or Gmi~ containing 2nmol of the 
with crude rat brain extract and different amounts of GD3 or respective antigen (i.e. 9.1, 5, and l0 nmol Gmix for staining with 
GDla added as indicated. Total lipid-bound sialic acid of brain cx- GMB16, GMR17, and GMRS, respectively) was absorbed to TLC 
tracts was 2.5 nmol per mg wet weight. After addition of standard plates and immunostained with the antibody indicated. For staining 
ganglioside, brain extract equivalent to 1.1 (a) or 0.15 nmol sialic with GMB16, the site of ganglioside application had been sur- 
acid (b) was coated per well. Values are means (+S.D.) of 3 or 4 rounded by a dotted line, for staining with GMR17 the centre of 
determinations each. Linear regression analysis was applied and the site of application had been marked. (b) Per lane 8 nmol Gmix 
curves were extrapolated towards y=0. was chromatographed and stained as indicated. 
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a. GMB16 b. GMR17 side antibodies in vitro also stress the question of the struc- 
1.2 T T tures revealed by the use of these antibodies in situ. Concern- 
+ +  I 1 ~ ing surfaces of tissue sections or cells the antiganglioside 
E o•8 T I antibodies may rather detect structures of homogeneous gang- 
= I lioside composition than ganglioside antigens that occur in 
I clusters with other ganglioside species. Besides the known 
0.4 features of ganglioside crypticity, this possibility should be ) T considered, whenever gangliosides are traced by antibodies. 
~ To test how ganglioside composition influences antibody 
0 0 clrl. 20% 22°/. 100'/0 ctrl. 20*/, 40% 100% binding, the convenient ELISA procedure could prove to be 
GM1 GM1 GM1 GDla GDla GDla a valuable tool. Thus it may contribute to a better under- 
80% in Grn~x 80% in Gr, ~ standing of antiganglioside antibody binding in immunohisto- 
GDla GM1 chemistry as well as in antibody-directed tumour detection 
Fig. 5. Reactivity of mAb GMB16 with 100 pmol of GM1 (a) or and therapy. 
mAb GMR17 with 100 pmol of GDla (b) in ELISA. Prior to ELI- 
SA the antibodies were incubated with lipid vesicle preparations (1 References 
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